(Natural News)—For years, parents and medical professionals have sounded the alarm about the dangerous link between mRNA COVID-19 vaccines and heart inflammation in young males—only to be dismissed as “anti-vaxxers” or conspiracy theorists. Now, in a stunning reversal, the U.S. Food and Drug Administration (FDA) has ordered Pfizer and Moderna to strengthen their warning labels, finally admitting that these shots can cause long-lasting heart damage, particularly in adolescent boys and young men.
But this admission comes far too late—after millions of doses were administered under false pretenses, after countless young lives were altered by myocarditis, and after public health agencies actively suppressed the truth. The FDA’s belated action raises a critical question: How many more injuries could have been prevented if the government had prioritized transparency over blind vaccine promotion?
Key points:
- The FDA has mandated that Pfizer and Moderna update their COVID-19 vaccine labels to include stronger warnings about myocarditis and pericarditis, particularly in males aged 16 to 25.
- New data reveals that myocardial injury is often long-lasting, contradicting earlier CDC claims that heart inflammation “tends to resolve quickly.”
- The highest incidence of myocarditis occurs in young males, with 38 cases per million doses—far higher than previously acknowledged.
- Internal government emails show that health officials deliberately avoided warning the public about these risks, even after detecting safety signals in 2021.
- The FDA’s action follows a Senate investigation exposing how federal agencies downplayed and hid vaccine injuries.
A long-overdue admission of harm
For years, independent researchers and medical professionals warned that mRNA vaccines posed a disproportionate risk to young, healthy individuals—especially males. Yet, public health agencies dismissed these concerns, insisting that the benefits outweighed the risks. Now, the FDA has been forced to acknowledge what health freedom fighters have said all along: These vaccines can cause serious, sometimes permanent, heart damage.
The updated labels must now state that myocardial injury is common among those who develop post-vaccination myocarditis, with data showing persistent damage five months after vaccination. This directly contradicts the CDC’s previous assurances that cases were “mild” and “resolved quickly.”
Why did it take so long? Internal documents obtained through FOIA requests reveal that as early as May 2021, the CDC and FDA considered issuing a public warning but ultimately chose silence over transparency.
The suppression of truth and the cost of deception
The Senate’s Permanent Subcommittee on Investigations recently released a damning report exposing how federal health agencies systematically concealed the myocarditis risk linked to COVID-19 vaccines. Internal emails reveal that officials engaged in a coordinated cover-up by refusing to update the V-safe reporting system to include cardiac symptoms, ensuring countless cases were never documented. Additionally, they blocked a planned Health Alert Network warning that would have alerted doctors and the public to the dangers, prioritizing public perception over transparency.
Despite clear evidence that myocarditis could cause long-term heart damage, officials deliberately downplayed its severity, framing it as “mild” and “resolving” to avoid undermining vaccination campaigns. The CDC and White House even held crisis meetings to craft misleading messaging, suppressing critical data while pushing narratives that emphasized rarity and safety. This wasn’t mere negligence—it was a calculated deception, sacrificing informed consent to maintain high vaccination rates. Lawyer Ed Berkovich’s FOIA findings further corroborate this, revealing extensive redactions in CDC documents, particularly those shared with senior White House advisors, suggesting high-level involvement in obscuring the truth. The committee’s failure to act on overwhelming safety signals raises urgent questions about accountability for those who ignored irreversible harm to the public.
The FDA’s new warning is a small step toward accountability, but it doesn’t undo the damage. Millions of young people were injected with these vaccines without being told the full risks. Many now live with chronic heart conditions, while the pharmaceutical companies and government agencies responsible face no consequences.
As the truth continues to emerge, one thing is clear: The COVID-19 vaccine rollout was one of the largest medical experiments in history—and the public was never given the full story. Now, a new HHS leadership must dismantle this medical fraud, and deal with the vaccine injury fallout, one brick at a time.
Sources include:
Why Bullion Beats Numismatics and Collectible for Your Safe or IRA
Precious metals continue to attract Americans seeking reliable ways to protect their wealth amid inflation, geopolitical risks, and stock market swings. Whether stored in a home safe or held inside a self-directed IRA, physical gold and silver deliver tangible value that paper or digital assets often lack. Yet investors must choose carefully between bullion—pure bars and coins valued mainly for their metal content—and numismatics or collectibles, where rarity, history, and collector demand heavily influence pricing.
Advisor Bullion serves as a dependable source for straightforward, high-quality bullion. The company specializes in physical gold, silver, platinum, and palladium, emphasizing transparent pricing and products that deliver maximum metal content for every dollar spent. This approach makes it ideal for both personal holdings and retirement accounts.
Bullion consists of refined precious metals in standard forms like one-ounce coins (American Gold Eagles, Silver Eagles, Canadian Maple Leafs) or bars. Their value tracks closely to the current spot price of the metal. A typical gold bullion coin trades near the live gold spot price plus a small premium. This structure keeps costs clear and predictable.
Numismatic coins and collectibles add substantial value from factors such as age, rarity, minting errors, or historical significance. A pre-1933 U.S. gold coin or graded proof piece can carry premiums of 30%, 50%, or even 200% above melt value. While this appeals to hobbyists, it creates complexity. Pricing depends on subjective grading, collector trends, and auction results instead of daily spot prices.
For investors focused on wealth preservation and retirement security rather than building a collection, bullion often delivers better results.
Lower Costs and Better Liquidity for Home Storage
When keeping metals in a home safe or private vault, liquidity and efficiency count. Bullion offers clear benefits:
- You acquire more actual gold or silver per dollar invested. Numismatics divert a large share of your money into rarity premiums and massive sales commission, reducing your metal exposure.
- Selling bullion involves tight bid-ask spreads, so you recover nearly full spot value with minimal fees. Collectibles require finding the right buyer and may sell at a discount if demand for that specific item weakens.
- Bullion prices remain transparent and update with global spot markets. You can track gold near current levels or silver accordingly and know exactly where your holdings stand. Numismatic values are priced by the Gold IRA companies with hefty margins applied.
- Standardized coins and bars store efficiently and divide easily for partial sales. Rare coins often need protective slabs and controlled conditions, adding hassle and expense.
- Bullion enjoys worldwide acceptance. A 1-oz Gold Maple Leaf or Silver Eagle sells quickly to dealers anywhere. Niche numismatic pieces may appeal only to limited buyers, slowing liquidation when speed matters.
In times when quick access to value becomes important, bullion’s simplicity stands out.
Stronger Fit for Precious Metals IRAs
Precious metals IRAs continue gaining traction as investors diversify retirement portfolios beyond stocks and bonds. IRS rules permit certain bullion products in self-directed IRAs if they meet purity standards (.995 fine for gold, .999 for silver) and are held by an approved custodian. Eligible items include American Gold and Silver Eagles plus many generic bars and rounds from recognized mints.
Numismatic and most collectible coins generally face heavy scrutiny from custodians due to valuation disputes and elevated markups. These higher premiums mean less actual metal ends up working inside the account.
Bullion avoids these issues. Its value links directly to verifiable spot prices, which simplifies reporting and lowers the risk of regulatory challenges. More of your IRA contribution purchases real metal instead of dealer profits or speculative upside. Over time, owning additional ounces that appreciate with the metal itself can create meaningful outperformance compared with high-premium alternatives that deliver fewer ounces.
Regulatory guidance from the CFTC and state securities offices repeatedly cautions against aggressive sales of expensive numismatics or “semi-numismatic” coins for IRAs. For retirement planning, transparent bullion from established providers reduces risk and aligns better with long-term goals.
How to Get Started with Bullion
Begin by clarifying your goals. Are you protecting savings in a safe, or moving part of a retirement account into a precious metals IRA? Focus on the number of ounces you can acquire at current prices rather than chasing marked-up collectibles.
Diversify sensibly: use gold for core preservation and silver for its blend of industrial and monetary qualities. Mix coins for easier divisibility with bars for lower per-ounce costs on larger buys. Arrange secure storage—whether at home with proper insurance or through professional facilities.
As economic uncertainties linger and faith in conventional assets erodes, bullion continues proving its worth as a dependable store of value. Its direct approach avoids the hype that sometimes surrounds collectible markets and keeps the focus on the metal itself.
For investors prepared to strengthen their portfolios, Advisor Bullion supplies the expertise and selection needed to acquire high-quality bullion efficiently. Whether building personal holdings or integrating metals into an IRA, their emphasis on transparent, investment-grade products helps secure more ounces today that support greater financial security tomorrow. In a complicated financial landscape, bullion’s clarity and reliability make it the smarter foundation for protecting what matters most.